How to reduce the risk of primary engraftment failure after haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia?

Background. Haploidentical hematopoietic stem cell transplantation (haplo‑HSCT) represents an important alternative for patients with acute myeloid leukemia (AML) who lack an HLA‑matched donor. However, the high incidence of primary graft failure remains a significant challenge. Optimizing transplan...

Full description

Bibliographic Details

Published in:	Онкогематология
Main Authors:	D. K. Zhogolev, S. N. Bondarenko, A. G. Smirnova, Yu. Yu. Vlasova, D. A. Chernyshova, I. S. Moiseev, A. D. Kulagin
Format:	Article
Language:	Russian
Published:	ABV-press 2025-03-01
Subjects:	haploidentical hematopoietic stem cell transplantation acute myeloid leukemia engraftment
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/1010